| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 07/17/2002 | EP1223176A2 Peptide mutant of human ERAB/HADH2, its X-ray crystal structure, and materials and method for identification of inhibitors thereof |
| 07/17/2002 | EP1223169A1 Agent for potentiating nerve growth factor activity containg 1,2-ethanediol derivate or salt thereof |
| 07/17/2002 | EP1223166A1 Linked cyclic polyamines with activity against hiv. |
| 07/17/2002 | EP1222463A2 Allosteric sites on muscarinic receptors |
| 07/17/2002 | EP1222188A1 Novel imidazopyridine carbonitrile compounds |
| 07/17/2002 | EP1222187A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 07/17/2002 | EP1222186A2 Condensed naphthyridines as hiv reverse transcriptase inhibitors |
| 07/17/2002 | EP1222182A2 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 07/17/2002 | EP0823254B1 Novel use of pyrazolopyridine compounds |
| 07/17/2002 | CN1358723A Novel bicyclic amino-pyrazino ketone compound, its preparation method and medicinal composition having same |
| 07/17/2002 | CN1358721A Process for preparing alooerine |
| 07/17/2002 | CN1358720A Three-site substituted beta-carboline novel compound having anti-HIV and anti-cancer activity |
| 07/17/2002 | CN1087740C New benzimidzole, benzoxazole and benzothiazole compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/17/2002 | CN1087737C Dihygropyridine derivatives as bradykinin ant agonists |
| 07/16/2002 | US6420558 Aminopiperidine derivates as integrin αvβ3 antagonists |
| 07/16/2002 | US6420390 Heteroarylpiperidines and their use as antipsychotics |
| 07/16/2002 | US6420384 Proton pump inhibitors |
| 07/16/2002 | US6420382 Tyrosine kinase inhibitors |
| 07/16/2002 | US6420381 Acyl-coa: cholesterol acyl transferase (acat) inhibitory activity, and is useful as an agent for treatment of hyperlipidemia and atherosclerosis. |
| 07/16/2002 | US6420373 9-N-Bicyclic nuceoside agents useful as selective inhibitors of proinflammatory cytokines |
| 07/16/2002 | US6420370 Pyrimidine derivatives and method of making and using derivatives |
| 07/16/2002 | US6420365 Imidazopyridines and related derivatives as selective modulators of bradykinin B2 receptors |
| 07/16/2002 | US6420359 5,11-Dihydro-11-ethyl-5-methyl-8-(2-((1-oxido-4-quinolinyl)oxy)ethyl)-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one for example; antiviral agents for HIV infection |
| 07/16/2002 | US6420316 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/16/2002 | CA2119511C Benzimidazole compounds, their use and preparation |
| 07/11/2002 | WO2002053568A1 Cholesterol biosynthesis inhibitors containing as the active ingredient tricyclic spiro compounds |
| 07/11/2002 | WO2002053565A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient |
| 07/11/2002 | WO2002053558A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 07/11/2002 | WO2002053543A1 Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 07/11/2002 | WO2002053534A1 Vla-4 inhibitors |
| 07/11/2002 | WO2002053099A2 Methods and compositions for treating periodontal disease |
| 07/11/2002 | WO2002038156A3 Methods of use of fluoroquinolone compounds against pathogenic helicobacter bacteria |
| 07/11/2002 | WO2002036734A3 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors |
| 07/11/2002 | WO2001022919A3 Spiro[bicyclic -azacycloalkyl and -cycloalkyl] derivatives and uses thereof |
| 07/11/2002 | US20020091261 Phthalazines with angiogenesis inhibiting activity |
| 07/11/2002 | US20020091134 Novel 4-phenyl substituted tetrahydroiso quinolines therapeutic use thereof |
| 07/11/2002 | US20020091124 Also used as an antimitotic and for direct and/or indirect inhibition of tubulin polymerization in mammalian |
| 07/11/2002 | US20020091122 Voltage-dependent |
| 07/11/2002 | US20020091119 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/11/2002 | US20020091118 Psychotherapeutic agents. |
| 07/11/2002 | US20020091117 Psychotherapeutic agents. |
| 07/11/2002 | US20020091116 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades |
| 07/11/2002 | US20020091113 Treatment of septic shock |
| 07/11/2002 | US20020091107 Treatment of psoriasis, arthritis, and toxicity due to chemotherapy. |
| 07/11/2002 | US20020091090 Somatostatin antagonists and agonists |
| 07/11/2002 | US20020091078 Treating diabetes, especially Type II diabetes |
| 07/11/2002 | CA2433174A1 Cholesterol biosynthesis inhibitor containing tricyclic compound having spiro union as effective component |
| 07/11/2002 | CA2432504A1 Methods and compositions for treating periodontal disease |
| 07/10/2002 | EP1221444A1 Fused imidazole compounds and remedies for diabetes mellitus |
| 07/10/2002 | EP1221441A2 LTA4 Hydrolase inhibitors |
| 07/10/2002 | EP1221440A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 07/10/2002 | EP1220857A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/10/2002 | EP1220854A2 Novel tropane analogs |
| 07/10/2002 | EP1220842A1 Cyclic amine compounds as ccr5 antagonists |
| 07/10/2002 | EP1220840A2 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| 07/10/2002 | EP0819128B1 Tricyclic compounds useful in the treatment of cell proliferative disorders |
| 07/10/2002 | EP0690862B1 Quinolone derivatives and processes for preparing the same |
| 07/10/2002 | CN1358185A Optically active quinoline carboxylic acid derivatives having T-pyrrolidine substues causing optical activity and process for preparing thereof |
| 07/10/2002 | CN1358182A 呼吸道合胞病毒复制抑制剂 Respiratory syncytial virus replication inhibitors |
| 07/10/2002 | CN1358181A 呼吸道合胞病毒复制抑制剂 Respiratory syncytial virus replication inhibitors |
| 07/10/2002 | CN1358180A Respiratory syncytial virus replication inhibitors |
| 07/10/2002 | CN1358178A Pharmaceutical compounds |
| 07/10/2002 | CN1087296C Process for preparing tetrahydro-indolizines |
| 07/10/2002 | CN1087283C New LH-RH antigonists with improved effectiveness |
| 07/09/2002 | US6417370 Arylphenyl-substituted cyclic keto-enols |
| 07/09/2002 | US6417221 Tropane analogs and methods for inhibition of monoamine transport |
| 07/09/2002 | US6417217 Prolines as antimicrobial agents |
| 07/09/2002 | US6417195 Isoquinoline derivatives and isoquinoline combinatorial libraries |
| 07/09/2002 | US6417194 Quinolines and quinazolines useful in therapy |
| 07/09/2002 | CA2104781C Process for imidazo[4,5-c]quinolin-4-amines |
| 07/09/2002 | CA2041224C Azatetracycle compounds |
| 07/04/2002 | WO2002051846A1 Apicidin-derivatives, their synthetic methods, and antitumor compositions containing the same |
| 07/04/2002 | WO2002051842A1 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 07/04/2002 | WO2002051841A1 Quinuclidine carbamate derivatives and their use as m3 antagonists |
| 07/04/2002 | WO2002051837A2 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/04/2002 | WO2002051835A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 07/04/2002 | WO2002051831A1 Oxybenzamides derivatives as factor xa inhibitors |
| 07/04/2002 | WO2002051810A2 Integrin receptor ligands |
| 07/04/2002 | WO2002017922A8 Bridged nicotine compounds for use in the treatment of cns pathologies |
| 07/04/2002 | WO2002014317A3 Substituted pyrazoles |
| 07/04/2002 | WO2001044260A9 Novel purines |
| 07/04/2002 | US20020086875 Use of nicergoline in the treatment of spasticity |
| 07/04/2002 | US20020086874 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents |
| 07/04/2002 | US20020086871 Pharmaceutical composition for the treatment of CNS and other disorders |
| 07/04/2002 | US20020086865 Use of growth hormone secretagogues for stimulating or increasing appetite |
| 07/04/2002 | US20020086863 New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| 07/04/2002 | CA2441896A1 Quinuclidine carbamate derivatives and their use as m3 antagonists |
| 07/04/2002 | CA2432654A1 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/04/2002 | CA2431471A1 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 07/03/2002 | EP1219626A1 Compounds for fluorescence labeling |
| 07/03/2002 | EP1219622A2 Pharmaceutical compositions for CNS and other disorders |
| 07/03/2002 | EP1219621A1 Azaindolizinone derivatives and cerebral function improvers containing the same as the active ingredient |
| 07/03/2002 | EP1219609A1 Aromatic nitrogenous six-membered ring compounds |
| 07/03/2002 | EP1218383A2 Bicyclic imidazo-5-yl-amine derivatives |
| 07/03/2002 | EP1218382A2 Bicyclic imidazo-3-yl-amine derivatives |
| 07/03/2002 | EP1218380A2 Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring |
| 07/03/2002 | EP1218378A2 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 07/03/2002 | EP1218374A1 Pharmaceutically active sulfonamide derivatives |
| 07/03/2002 | EP1218373A2 2-pyrazolin-5-ones as tyrosine kinase inhibitors |
| 07/03/2002 | EP1218360A1 Triazine kinase inhibitors |